Maraviroc, a CCR5 antagonist, prevents development of hepatocellular carcinoma in a mouse model

被引：0
|
作者：
Ochoa-Callejero, Laura [1 ]
Perez-Martinez, Laura [1 ]
Rubio-Mediavilla, Susana [2 ]
Oteo, Jose A. [1 ]
Martinez, Alfredo [1 ]
Blanco, Jose R. [1 ]
机构：
[1] Ctr Biomed Res La Rioja CIBIR, Logrono, Spain
[2] Hosp San Pedro, Logrono, Spain
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/1538-7445.AM2012-LB-173
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LB-173
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Maraviroc, a CCR5 Antagonist, Prevents Development of Hepatocellular Carcinoma in a Mouse Model
    Ochoa-Callejero, Laura
    Perez-Martinez, Laura
    Rubio-Mediavilla, Susana
    Oteo, Jose A.
    Martinez, Alfredo
    Blanco, Jose R.
    PLOS ONE, 2013, 8 (01):
  • [2] MARAVIROC, A CCR5 ANTAGONIST, PREVENTS DEVELOPMENT OF HEPATOCELLULAR CARCINOMA IN A MOUSE MODEL
    Ochoa-Callejero, L.
    Perez, L.
    Rubio, S.
    Oteo, J. A.
    Martinez, A.
    Blanco, J. R.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S437 - S437
  • [3] Maraviroc: a new CCR5 antagonist
    Sayana, Shilpa
    Khanlou, Homayoon
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2009, 7 (01) : 9 - 19
  • [4] Maraviroc, a CCR5 antagonist, prevents the development of hepatic steatosis in a mouse model of non-alcoholic fatty liver disease (NAFLD)
    Perez-Martinez, L.
    Perez-Matute, P.
    Aguilera-Lizarraga, J.
    Rubio, S.
    Narro, J.
    Ochoa-Callejero, L.
    Oteo, J. A.
    Blanco, J. R.
    ANTIVIRAL THERAPY, 2013, 18 : A69 - A69
  • [5] Treatment of HIV infection with the CCR5 antagonist maraviroc
    Kromdijk, Wiete
    Huitema, Alwin D. R.
    Mulder, Jan Willem
    EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (07) : 1215 - 1223
  • [6] Maraviroc - The first CCR5 antagonist for the treatment of HIV
    Girotto, Jennifer E.
    FORMULARY, 2007, 42 (10) : 601 - 608
  • [7] Maraviroc: A coreceptor CCR5 antagonist for management of HIV infection
    Yost, Raymond
    Pasquale, Timothy R.
    Sahloff, Eric G.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2009, 66 (08) : 715 - 726
  • [8] Study of intracellular and immunomodulant effects of CCR5 Antagonist Maraviroc
    Sauzullo, I.
    Mengoni, F.
    Rossi, R.
    Celardo, I.
    Ghibelli, L.
    Lichtner, M.
    Massetti, A. P.
    Mastroianni, C. M.
    Vullo, V.
    INFECTION, 2010, 38 : 92 - 93
  • [9] Overcoming HERG affinity in the discovery of the CCR5 antagonist maraviroc
    Price, David A.
    Armour, Duncan
    de Groot, Marcel
    Leishman, Derek
    Napier, Carolyn
    Perros, Manos
    Stammen, Blanda L.
    Wood, Anthony
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (17) : 4633 - 4637
  • [10] Preparation and Activities of Macromolecule Conjugates of the CCR5 Antagonist Maraviroc
    Asano, Shigehiro
    Gavrilyuk, Julia
    Burton, Dennis R.
    Barbas, Carlos F., III
    ACS MEDICINAL CHEMISTRY LETTERS, 2014, 5 (02): : 133 - 137
12345